(Q79815991)

English

A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice

scientific article published on 07 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Vibrio cholerae

1 reference

based on heuristic

inferred from title

author name string

José Luis Pérez

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Reinaldo Acevedo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Adriana Callicó

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yovania Fernández

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bárbara Cedré

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Gemma Año

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Lissette González

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Gustavo Falero

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Arturo Talavera

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Oliver Pérez

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Luis García

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

7 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

205-212

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Live oral cholera vaccine : from principle to product

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Cholera vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

A review of vaccine research and development: human enteric infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Production and characterization of a monoclonal antibody against mannose-sensitive hemagglutinin of Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Molecular cloning and transcriptional regulation of ompT, a ToxR-repressed gene in Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Vibrio cholerae OmpU and OmpT porins are differentially affected by bile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Lipopolysaccharides of Vibrio cholerae: III. Biological functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

New vaccines require potent adjuvants like AFPL1 and AFCo1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of outer membrane protein OmpU of Vibrio cholerae O1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.052

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.10.052

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18996426%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79815991&oldid=1708018029"